Skip to main content
. 2021 Aug 9;58(3):450–456. doi: 10.1002/uog.23729

Table 5.

Obstetric, delivery and neonatal outcomes of 57 pregnant women who received two doses of BNT162b2 vaccine

Outcome Value
Gestational age at birth (weeks) 39.5 (38.7–40.0)
Premature delivery < 37 weeks 0 (0)
Birth weight (g) 3269 ± 410
Miscarriage or IUFD 0 (0)
PIH or pre‐eclampsia 1 (1.8)
SGA 3 (5.3)
Gestational diabetes 4 (7.0)
Placental abruption 2 (3.5)
Oligohydramnios 1 (1.8)
Polyhydramnios 2 (3.5)
Induction of labor 17 (29.8)
Vacuum/forceps‐assisted delivery 2 (3.5)
Elective Cesarean section 3 (5.3)
Emergency Cesarean section 7 (12.3)
Postpartum hemorrhage 6 (10.5)
Endometritis 1 (1.8)
Neonatal death 0 (0)
Neonatal CPR 0 (0)
Neonatal oxygen support 2 (3.5)
Neonatal invasive ventilation 2 (3.5)
Neonatal fever 0 (0)
NICU hospitalization* 2 (3.5)

Data are given as median (interquartile range), n (%) or mean ± SD.

*

Two neonates were hospitalized in neonatal intensive care unit (NICU) after birth, both due to requirement for invasive ventilation; one of them was diagnosed with respiratory distress syndrome.

CPR, cardiopulmonary resuscitation; IUFD, intrauterine fetal demise; PIH, pregnancy‐induced hypertension; SGA, small‐for‐gestational age (birth weight < 10th centile).